EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy - Benzinga
Anixa Biosciences, Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.70
+4.5% in 3d after detection
Post-detection moves
1h
—
1d
+2.2%
3d
+4.5%
7d
+1.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS